First salvage treatment in patients with advanced germ cell cancer after cisplatin-based chemotherapy: analysis of a registry of the German Testicular Cancer Study Group (GTCSG).

Lars Arne Berger,Carsten Bokemeyer,Anja Lorch,Marcus Hentrich,Hans-Georg Kopp,T. Gauler,Jörg Beyer,Maike de Wit,Frank Mayer,Ina Boehlke,Christoph Oing,Friedemann Honecker,Karin Oechsle

First salvage treatment in patients with advanced germ cell cancer after cisplatin-based chemotherapy: analysis of a registry of the German Testicular Cancer Study Group (GTCSG).

2014

Lars Arne Berger
Carsten Bokemeyer
Anja Lorch
Marcus Hentrich
Hans-Georg Kopp
T. Gauler
Jörg Beyer
Maike de Wit
Frank Mayer
Ina Boehlke
Christoph Oing
Friedemann Honecker
Karin Oechsle

Purpose We analyzed prognostic categories at first relapse according to the International Prognostic Factors Study Group (IPFSG) criteria as well as the efficacy of salvage treatment.

Keywords:

Cisplatin
Cancer research
Cancer
Gynecology
Pathology
German
Chemotherapy
Germ cell
Testicular cancer
Biology
Young adult
Oncology
Hematology
Survival analysis
salvage treatment
Retrospective cohort study
Internal medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations